TAMPA, Fla., June 15, 2004 (PRIMEZONE) -- Rx Processing Corporation (Pink Sheets: RXPC) announces today it is now listed and has begun trading on the over-the-counter "Pink Sheets" under the ticker symbol the RXPC.
Rx Processing is in the business of providing U.S. citizens with access to low cost Canadian prescription pharmaceuticals. Current International pricing controls regulate the prices pharmaceutical companies can charge in their local market. The Company under the U.S. Government's Meds Act of 2000, provides U.S. citizens with access to these low cost prescription drugs. Utilizing Rx Processing, U.S. citizens can save between 25% - 84% on their daily prescriptions. These reduced cost medications are available at the Company's retail storefronts and through the website (www.mycanadadrugs.com).
In December of 2003, Rx Processing partnered with a Canadian licensed pharmacy group with over 30 years experience, and currently lists over 1500 name brand and generic medications for virtually every medical need. Example of the potential savings:
Lipitor Leading U.S. Price 289.90 for 90 pills / 20 mg
Our Price 172.89 for 90 pills / 20 mg
Celebrex Leading U.S. Price 256.65 for 100 pills / 200 mg
Our Price 127.13 for 100 pills / 200 mg
Peter Fiorillo, CEO of Rx Processing commented, "This is a major step forward that will facilitate Rx Processing's growth and access to capital markets. The focus of the Company is simple - give people low cost and legal access to the prescription drugs they need to improve the quality of their life. There are many misconceptions about the legality and safety of importing prescriptions. Recent legislation, however, has provided access to this low cost alternative and has paved the way for us to grow our business rapidly and extend these saving to as many people as possible. Our core competencies are reliability, access to a broad range of medications and ease of transaction. We look forward to building Rx Processing's market share in the coming quarters."
Safe Harbor Statement
All statements other than statements of historical fact included in this press release are "forward-looking statements." The forward-looking statements, including statements about the Company's future expectations, including future revenues and earnings, and all other forward-looking statements (i.e., future operational results and sales) are subject to assumptions and beliefs based on current information known to the Company and factors that are subject to uncertainties, risk and other influences, which are outside the Company's control, and may yield results differing materially from those anticipated.